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Abstract The histidine at position 1106 of the C4B isotype of 
human complement is involved in catalyzing the covalent binding 
of the thioester to glycerol and water. By replacing the histidine 
with other residues, it was found that tyrosine is also capable of 
mediating the reaction. We propose that they act as nucleophiles 
by first attacking the thioester, upon activation, to form acyl 
intermediates, which subsequently react with the hydroxyl groups 
of glycerol or water. The monomeric a-macroglobulin, ~113 of 
the rat, was also studied. Unlike ot2-macroglobulin , which is a 
tetramer, alI3 has binding properties imilar to those of C4A. 
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1. Introduction 
The covalent binding of the activated forms of the comple- 
ment proteins C3 and C4 to immune complexes and pathogens 
is a key step in their elimination [1,2]. This reaction is made 
possible by the internal thioester in C3 and C4. Activation of 
these proteins involves the cleavage of a single peptide bond, 
splitting C3 into C3a and C3b, and C4 into C4a and C4b. It 
is thought that concomittant conformational changes take 
place in the major fragments C3b and C4b, resulting in the 
exposure of the thioester bond, which becomes reactive with 
nucleophiles. The most abundant nucleophiles in biological 
systems are the hydroxyl and amino groups found on carbohy- 
drates and proteins, which react with the thioester to form ester 
and amide bonds. Although this description of the binding 
reaction is generally correct, it cannot account for the differ- 
ence between C3 and C4 in their reaction with hydroxyl and 
amino groups. Whereas C3b reacts predominantly with hy- 
droxyl groups at neutral pH, C4 reacts with both amino and 
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hydroxyl groups (see later) [3]. ~2macroglobulin (~2M), another 
protein with an internal thioester, reacts only with amino 
groups with low efficiency [4]. 
The two isotypes of human C4, C4A and C4B, have been 
most useful in the investigation of this binding reaction. They 
differ by only four amino acids within the sequence of six 
residues from position l l01 to 1106, but have very different 
binding properties. C4A, with the residues PCPVLD in the 
1101-1106 hexapeptide, reacts efficiently with amino groups 
but poorly with hydroxyl groups, whereas C4B, with the se- 
quence LSPVIH, reacts moderately with both nucleophilic 
groups [5-8]. Using site-directed mutagenesis atthe cDNA level 
followed by expression of the modified proteins, it was found 
that the key residue lies in position 1106. The His at this posi- 
tion is crucial in conferring C4B-like binding acitivity whereas 
an Asp, Asn or Ala at this position renders the protein C4A-like 
[9,10]. Based on these observations, it was argued that the His 
of C4B plays a role in catalyzing the reaction of the thioester 
with hydroxyl groups on water and other compounds; thus, its 
reaction with amino groups is apparently less effective. C4A, 
on the other hand, does not have a His at position 1106. The 
thioester, once exposed upon activation, is hydrolyzed more 
slowly and so reacts more efficiently with amino groups. This 
interpretation is supported by the kinetics of the binding reac- 
tion with respect o that of activation of C4A and C4B. As 
predicted, the half-life of the exposed thioester in C4A is sub- 
stantially longer (~ 10 s at 22°C) than that of C4B (< 1 s and not 
measureable in the experiment) [10]. 
The importance of the His of C4B in catalyzing a reaction 
with hydroxyl groups may also be applicable in C3 since the 
binding properties of C3 and C4B are similar [4]. However, it 
is more difficult to reconcile the differences between C4A and 
~2 M since their reactivities with glycine differ by 100-fold [4] 
and replacement of the residues 1101-1106 of C4 with the 
corresponding ones of ~2 M (SGSLLN) yielded a C4A-like mol- 
ecule [10]. In this paper, we report our investigation on the role 
of the residue at position 1106 by replacing it with other basic/ 
nucleophilic residues, namely cysteine (C4-H1106C), lysine 
(C4-H1106K), serine (C4-H1106S), arginine (C4-H1106R) and 
tyrosine (C4-H1106Y). In addition, we report our finding on 
~l-inhibitor-3 (~113), a monomeric ~-macroglobulin of the rat, 
which, when activated with a non-binding protease, has binding 
properties imilar to those of C4A. 
Abbreviations: ~I3, ~-inhibitor 3; ~2M, c~zmacroglobulin; Cls, acti- 
vated complement subcomponent ofC1; EA, sheep erythrocytes coated 
with sensitizing antibody; EAC1, EA with activated C1 on the cell 
surface; HNE, human neutrophil elastase. 
2. Materials and methods 
C4 variants, in pBluescript (KS-), were generated from a C4 cDNA 
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clone coding for the B2 allotype as described [10]. The oligonucleotides 
used for introducing the various residues in position 1106 were: 
G9C for cysteine 
GIOK for lysine 
G11R for arginine 
GI2S for serine 
GI3Y for tyrosine 
(CCCTGCATGCTCCTACATATCACTGGAG); 
(CCCTGCATGCTCCTCT__TTTATCACTGGAG); 
(CCCTGCATGCTCCTACGATTCACTGGAG); 
(CCCTGCATGCTCCTACTTATCACTGGAG) and 
(CCCTGCATGCTCCTATATATCACTGGAG). 
After sequence confirmation, the cDNA inserts were transferred to 
the pEE6.HCMV.GS plasmid (a gift from Celltech Ltd) and transfected 
into CHO-KI cells by calcium phosphate precipitation using the rea- 
gents in the Mammalian Transfection kit (Strategene). Clones express- 
ing the C4 variants were screened for C4 hemolytic acitivity (for C4- 
HI 106R, C4-H1106S and C4-H1106Y) or C4 antigenic activity (for 
C4-H1106C and C4-H1106K). Postive clones were grown up and C4 
was purified from the culture supernatant by ion exchange chromatog- 
raphy on Q-Sepharose followed by affinity chromatography on a 
LOO3 (monoclonal ntibody against human C4) column. C4 was fur- 
ther purified by ion exchange on a mono-Q column using the same 
buffer and elution conditions as for the Q-Sepharose [10]. 
C4 hemolytic activity was measured using sensitized sheep erythro- 
cytes (EA) and C4 deficient guinea pig serum [11]. C4b bound to sheep 
erythrocytes bearing activated C1 (EAC1) was detected with ~SI-la- 
beled F(ab')2 fragments of rabbit anti-human C4 [6]. [3H]glycine and 
[3H]glycerol (Amersham) binding to C4 [12], and the pH dependence 
of binding [3,6], were performed as described previously. Rat C~ll3 was 
prepared according to [13] and human neutrophil elastase (HNE) was 
a gift from J. Travis. Rat ~113 and HNE were incubated at 37°C in a 
molar ratio of 60:1 for 30 min in the presence of [3H]glycine or [3H]glyc- 
erol. The amount of glycine or glycerol covalently bound to the protein 
was determined by the same method used for C4. 
C4 antigenic activity was determined by the inhibition of the binding 
of a rabbit anti-C4 antiserum to microtiter wells coated with human C4. 
50/11 of C4 containing samples were incubated with an equal volume 
of rabbit anti-C4 antiserum (1:160,000 dilution in PBS containing 2% 
w/v bovine serum albumin) at 37°C for 60 rain. The mixtures were then 
transferred to microtiter wells each precoated with 100 ng of human C4 
and incubated for 45 min. After washing, 100/~1 of sheep anti-rabbit 
IgG-alkaline phsophatase conjugate (hl000 dilution; Sigma) was 
added and incubated for 60 min at 37°C. The wells were washed and 
100 HI ofp-nitrophenyl phosphate (1mg/ml) was added. Color intensity 
at 405 nm was determined after 20-30 min at room temperature. The 
amount of C4 in the sample was determined by comparison to a curve 
obtained from controls with known amounts of C4. 
3. Results 
Stable CHO cell lines secreting C4-HI106C, C4-Hl l06K,  
C4-H1106R, C4-H1106S and C4-H1106Y were obtained. High 
levels of C4 antigenic activities were detected in the culture 
supernatant of the C4-Hl106C cell lines but no C4 specific 
hemolytic activity was detected. C4 purified from the superna- 
tant, by following antigenic activity, did not give the character- 
istic three-chain structure of C4 in SDS-PAGE analysis under 
reducing conditions (data not shown). It was concluded that the 
replacement of the His with a Cys at position 1106 did not yield 
a stable protein. 
Hemolytically active C4 was purified from the cell lines ex- 
pressing the other four C4 variants. Since the C4 proteins from 
the different cell lines were expected to have different binding 
and therefore different hemolytic activites, the amount of active 
C4 in each preparation was determined by [3H]methylamine 
incorporation. Other activities were normalized to the amount 
of active C4 in the preparations. 
The specific hemolytic activities of the four C4 variants, 
together with plasma C4A and C4B, are shown in Fig. 1. As 
expected, C4B showed ~3 times the specific hemolytic activity 
of C4A. The four C4 variants have lower hemolytic activities 
with C4-H1106K only -1% that of C4B. The C4 proteins, at 
several concentrations, were incubated with EAC1. The 
amount of C4b bound to the erythrocytes was determined by 
the subsequent binding of ~25I-labeled anti-C4 F(ab' h. Thus, the 
relative binding activities of the C4 variants to EACI  correlates 
with their specific hemolytic activities. 
Relative 
Hemolytic 
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O C4B 100.0 
~ 300' 
• C4A 36.1 
e-, 200" [] C4-Hll06Y 18.5 
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Fig. 1. The binding of C4 to EAC1 cells. Different amounts of C4A, C4B and their variants were incubated with sheep erythrocytes coated with 
antibody and C1. Activation of C4 results in the covalent binding of the activated C4b fragment on the cell surface. The amount of C4b bound was 
determined by ~25I-labeled F(ab')2 fragment of rabbit anti-human C4. The hemolytic activities of the C4 variants are also shown relative to that of 
C4B, taking the value for C4B as 100. 
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Fig. 2. Binding of [3H]glycine (a) and [3H]glycerol (b) to C4A, C4B and the two variants C4-H1106Y and C4-H1106K as a function of pH. The 
concentration f glycine used for C4A (o) was 12.5/.tM, C4B (©) 2.5 mM, C4-H1106Y (~) 0.5 mM and C4-H1106K (m) 5 mM to give medium range 
binding values. The concentration f glycerol used was 15 mM for both C4B and C4-H1106Y. 
We also examine the effect of the residue at position 1106 on 
the C4 binding to amino and hydroxyl groups using glycine and 
glycerol as representative compounds. C4 was incubated with 
[3H]glycine or [3H]glycerol in the presence of activated Cls, 
which splits C4 to yield C4a and C4b. The reactions were 
Table 1 
Glycine and glycerol binding activity of C4, its variants and other 
thioester proteins 
Residues k/k  o (M i) 
1101 1106 
Glycine t Glycerol 2
C4A PCPVLD 16,300 0.6 
C4B LSPV IH  75 16.6 
C4-H1106K LSPV IK  65 0.3 
C4-H 1106R LSPVIR  1,500 0.1 
C4-H 1106S L S PVI S 5,500 0.7 
C4-H 1106Y LSPVIY 850 6.5 
C4-(~2M) 3 SGSLLN 15,300 1.0 
0~2 M4 SGSLLN 206 1.2 
Rat  ~13 SGSLLN 5,500 1.5 
The experiments were carried out at different concentrations of glycine 
to give non-saturating binding. The glycine concentrations were 0.1 
mM for C4A, C4-H1106S, C4-(0~:M) and rat ~I3, 1 mM for C4- 
H1106R and C4-H1106Y, and 2.5 mM for C4B, C4-H1106K and c~2M. 
2All experiments were carried out at a glycerol concentration of
10 raM. 
3 C4 with the residues 1101 1106 substituted with those of ~2M, data 
from ref. [10]. 
4 Human c~2M, data from [4]. Values are expressed as per mol of mon- 
omeric subunit of the ~2M tetramer. 
allowed to proceed to completion (15 min). Binding efficiency 
(BE) is defined as the fraction of C4b bound with either glycine 
or glycerol. Thus, BE -- k2[G]/(ko + k2[G]), where k 2 is the sec- 
ond-order ate constant of binding to glycine or glycerol, [G] 
the concentratrion of the small molecules in the experiments 
and k0 the first-order hydrolysis rate of the thioester. The kflko 
values for the binding of the thioester proteins to glycine and 
glycerol, calculated as BE/[G](1 - BE), are shown in Table 1. 
The concentration of glycerol was 10 mM for all C4 variants. 
However, different amounts of glycine were used since the 
reactivity of the C4 variants to glycine span a large range. All 
four variants howed some level of binding to glycine but only 
C4-H1106Y showed significant binding to glycerol. 
The effect of pH on the binding activities of the C4 variants 
was also investigated (Fig. 2a). The binding of C4-H1106K and 
C4-H1106Y to glycine are relatively insensitive to pH. C4A, 
C4B, as well as C4-Hl l06R and C4-H1106S (not shown), on 
the other hand, bind more effectively at higher pH. Glycerol 
binding activities of C4B and C4-H 1106Y were not significantly 
affected by pH (Fig. 2b). 
The ~113 of the rat, a monomeric member of the ~-mac- 
roglobulin family, was also studied for its binding activity to 
glycine and glycerol. Human neutrophil elastase (HNE) does 
not have any lysine residues and does not bind covalently to 
~113 and, presumably, for this reason, its protease activity is not 
inhibited by cqI3 [13]. It was therefore chosen to activate ~113 
in these experiments. The binding results are included in Table 
1. Unlike human c~2M, which is a tetramer, c~I3 showed sub- 
stantial binding to glycine. No significant binding to glycerol 
can be detected. 
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4. Discussion 
We have constructed five C4 variants with the His at position 
1106 substituted with Cys, Lys, Ser, Arg and Tyr. The back- 
ground C4 sequence is that of C4B of the B2 allotype. 
Although large quantities of C4 could be detected antigeni- 
cally from the culture supernatant of C4-H1106C transfected 
cells, no C4 hemolytic acitivity could be detected. The introduc- 
tion of a Cys residue at position 1106 is apparently sufficient 
to prevent proper synthesis of the protein, possibly by disrupt- 
ing the normal course of disulphide bond formation. However, 
it should be noted that C4A has a cysteine at position 1102 and 
this does not affect the structure, and function, of the protein. 
The other four constructs yielded active C4 proteins. The 
level of active C4 was quantitated by the covalent incorporation 
of [3H]methylamine to the thioester site. Determinations of 
other properties of C4 are normalized to methylamine incorpo- 
ration. All four variants have lower specific hemolytic activities 
when compared with C4B and C4A. The difference in specific 
hemolytic activity can be correlated with the ability of the 
proteins to bind EAC1 cells, which can in turn be correlated 
with the binding activities to glycine and glycerol. Since sheep 
erythrocytes have large amounts of carbohydrate on the cell 
surface in the form ofglycoproteins and glycolipids, the binding 
of the C4 proteins to cells is primarily reflective of their capacity 
to react with hydroxyl groups. 
We have previously shown that the difference in the binding 
activities between C4A and C4B is due to the His at position 
1106 of C4B. We conjectured that the His plays a part in 
catalyzing the reaction of water and other hydroxyl groups with 
the internal thioester upon activation. In the absence of the His, 
hydrolysis of the thioester isnot catalysed, thus, it is susceptible 
to the nucleophilic attack by the amino groups, such as that on 
a glycine molecule [10]. The mechanistic role of the His was not 
defined. 
The substitution of H 1106 with other basic/nucleophilic resi- 
dues resulted in C4 variants with very different binding proper- 
ties. All four variants how intermediate glycine binding activ- 
ity with respect to C4A and C4B. In addition, C4-H1106Y also 
shows a significant level of glycerol binding. Thus, in any cata- 
lytic mechanism proposed for the reaction of hydroxyl groups 
with the 'exposed' thioester, His and Tyr, at position 1106, have 
to assume quivalent functional roles in the mechanism. Since 
the pK a of the imidazole group of His is -6.0 and that of the 
phenolic group of Tyr is ~ 10.0, it is difficult o propose a model 
involving these residues either both as acids or both as bases 
at neutral pH. 
An alternative mechanism is that either group can act as a 
nucleophile, which necessarily predicts an intermediate. This 
hypothesis is possible although the phenolic group of Tyr 
would be less effective and may account for the difference in 
glycerol binding between C4B and C4-H1106Y. Furthermore, 
we can extend our hypothesis to explain the binding activity of 
C4-H1106K. The &amino group of Lys can attack the thioester 
to form a stable acyl-amide bond. Thus, C4-H1106K has very 
low specific hemolytic activity and glycine binding can only be 
detected at relatively high concentration (>2.5 raM) (Fig. 1, 
Table 1). Both the guanidinium group of Arg and the hydroxyl 
group of Ser are poor nucleophile at neutral pH and they do 
not promote the binding of C4-Hll06R and C4-H1106S to 
hydroxyl groups. Indeed, this hypothesis finds support in the 
pH dependence of glycine binding to the C4 variants. Since the 
pKa of the &amino group of Lys and the phenolyic group of 
Tyr are ~ 10.5 and ~ 10.0, respectively, they would be effective 
competitors with the s-amino group of glycine (pKa ~ 9.5) over 
the pH range of 7.5-9.0. Thus, a relatively similar level of 
glycine binding to C4-HII06K and C4-1106Y is observed 
across this pH range. However, we are still left with the problem 
of how the reaction proceeds from the acyl intermediates. In 
particular, a base may still be required to catalyze the reaction 
between the acyl intermediates and oxygen nucleophiles. Fur- 
thermore, it seems unnecessarily complex to have one activated 
awl group (the thioester) replaced by another (acyl-imidazole 
or awl-phenol) in the reaction. 
C4A and human ~2M do not have a His at position 1106 and 
they do not bind glycerol. However, their binding to glycine 
differs significantly (Table 1). In addition, when the residues 
1101 to 1106 of C4 was replaced by those of ~2M, the resultant 
molecule has binding properties like C4A but not ~2M [10]. 
Unlike C4, which does not bind Cls during activation, ~2M is 
known to bind the activating proteases [13]. Thus, potiential 
competition between the activating proteases and ligand for 
covalent binding poses difficulties in the interpretation f bind- 
ing data of~2M. Further difficulties also arise from the fact that 
human ~2M is a tetramer [14,15] and negative cooperativity 
between the subunits has been demonstrated for their reaction 
with the activating proteases [15-17]. The rat ~I3 is a monom- 
eric ~-macroglobulin and has the identical sequence of 
SGSLLN as ~2M in the region of interest. It is also not an 
inhibitor of HNE, nor does it bind the enzyme covalently. Thus, 
a system using ~I3  and low levels of HNE affords a better 
comparison to C4 binding by eliminiating several confounding 
factors. Indeed, ~I3 shows similar binding properties to C4A 
and C4-(~zM ) (Table 1). 
In this paper, we have shown that the covalent binding reac- 
tion ofmonomeric ~-macroglobulins are C4A-like. In addition, 
we have obtained results suggesting that the His residue at 
position 1106 of C4B may act as a nucleophile and that the 
reaction may proceed by first forming an acyl-imidazole inter- 
mediate. We are currently engaged in experiments to test 
whether this hypothesis is correct, by showing that such an 
intermediate exists and by identifying the base necessary to 
catalyze the subsequent reaction of the intermediate with sub- 
strate molecules. 
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